Literature DB >> 29787011

P16INK4a as a progression/regression tumour marker in LSIL cervix lesions: our clinical experience.

S G Vitale, G Valenti, A M C Rapisarda, I Cali, I Marilli, M Zigarelli, G Sarpietro, A Cianci.   

Abstract

PURPOSE OF INVESTIGATION: The aim of this prospective study was the evaluation of low-grade intraepithelial lesion (LSIL) lesions evolvement in woman with evidence of high risk HPV infection and p 16 4a negative expression.
MATERIALS AND METHODS: 150 women with cytological diagnosis of LSIL were selected to be underwent to three years of follow-up consisting in smear test, colposcopy, and protein p16I4a investigation every six months and HPV-test every 12 months. RESULT: Final follow-up showed 45 cases of spontaneous lesion regression and 42 cases of persistence with absence of protein p164NK4a in all of them. There were three cases of disease progression to CIN2, two at 18-month follow-up and one at last follow-up. Disease progression was characterized of p16NK4a expression.
CONCLUSION: p16l4a should help to identify which LSIL cases are inclined to the progression of the disease and focalize which patients are eligible for specific treatment.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 29787011

Source DB:  PubMed          Journal:  Eur J Gynaecol Oncol        ISSN: 0392-2936            Impact factor:   0.196


  13 in total

Review 1.  Tumor markers of uterine cervical cancer: a new scenario to guide surgical practice?

Authors:  Gaetano Valenti; Salvatore Giovanni Vitale; Alessandro Tropea; Antonio Biondi; Antonio Simone Laganà
Journal:  Updates Surg       Date:  2017-09-16

2.  Net survival of patients with colorectal cancer: a comparison of two periods.

Authors:  Zdravko Štor; Rok Blagus; Alessandro Tropea; Antonio Biondi
Journal:  Updates Surg       Date:  2019-06-12

3.  Characteristics and Treatments of Patients Aged 65 Years or Over with Cervical Cancer.

Authors:  Shangdan Xie; Shuya Pan; Shuangwei Zou; Haiyan Zhu; Xueqiong Zhu
Journal:  Clin Interv Aging       Date:  2020-06-03       Impact factor: 4.458

4.  The expression of special AT-rich binding protein 1 in cervical cancer and its clinical significance.

Authors:  Lijie Zhao; Yuhua Zheng; Yong Ji; Xiaoying Zhang
Journal:  Onco Targets Ther       Date:  2019-01-30       Impact factor: 4.147

5.  A preliminary cervical cancer screening cascade for eight provinces rural Chinese women: a descriptive analysis of cervical cancer screening cases in a 3-stage framework.

Authors:  Shu-Xia Wang; Jiu-Ling Wu; Rui-Min Zheng; Wei-Yi Xiong; Jing-Yi Chen; Lan Ma; Xiao-Min Luo
Journal:  Chin Med J (Engl)       Date:  2019-08-05       Impact factor: 2.628

6.  Predictors of Absent High-grade Cervical Intraepithelial Neoplasia (CIN) in Loop Electrosurgical Excision Procedure Specimens of Patients with Colposcopic Directed Biopsy-Confirmed High-Grade CIN

Authors:  Yenrudee Poomtavorn; Chamnan Tanprasertkul; Araya Sammor; Komsun Suwannarurk; Yuthadej Thaweekul
Journal:  Asian Pac J Cancer Prev       Date:  2019-03-26

7.  Survival After Abdominal Q-M Type B versus C2 Radical Hysterectomy for Early-Stage Cervical Cancer.

Authors:  Chunlin Chen; Wuliang Wang; Ping Liu; Pengfei Li; Lu Wang; Shuangling Jin; Xiaonong Bin; Jinghe Lang
Journal:  Cancer Manag Res       Date:  2019-12-31       Impact factor: 3.989

Review 8.  Fertility preservation in women affected by gynaecological cancer: the importance of an integrated gynaecological and psychological approach.

Authors:  Valentina Lucia La Rosa; Simone Garzon; Giuseppe Gullo; Michele Fichera; Giovanni Sisti; Pasquale Gallo; Gaetano Riemma; Antonio Schiattarella
Journal:  Ecancermedicalscience       Date:  2020-05-06

9.  Serum exosomal microRNA-34a as a potential biomarker in epithelial ovarian cancer.

Authors:  Kazuya Maeda; Hiroshi Sasaki; Shoko Ueda; Shunsuke Miyamoto; Shinichi Terada; Hiromi Konishi; Yuhei Kogata; Keisuke Ashihara; Satoe Fujiwara; Yoshimichi Tanaka; Tomohito Tanaka; Masami Hayashi; Yuko Ito; Yoichi Kondo; Takahiro Ochiya; Masahide Ohmichi
Journal:  J Ovarian Res       Date:  2020-04-26       Impact factor: 4.234

10.  Evaluation of PCR-Reverse Dot Blot Human Papillomavirus Genotyping Test in Predicting Residual/Recurrent CIN 2+ in Posttreatment Patients in China.

Authors:  Qiaoyu Zhang; Binhua Dong; Lihua Chen; Tingting Lin; Yao Tong; Wenyu Lin; Haifeng Lin; Yuqin Gao; Fen Lin; Pengming Sun
Journal:  Cancer Manag Res       Date:  2020-04-01       Impact factor: 3.989

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.